← All updates

Nicholas Investment Partners, L.P.

Nicholas Investment Partners files Q1 2026 13F with about $1.4 billion in reported value fields

May 15, 2026 filing Manager profile

Summary: Nicholas Investment Partners, L.P. filed a public Form 13F-HR for the quarter ended 2026-03-31, reporting 205 listed positions and about $1.4 billion in SEC information-table value fields. The top reported entries included BWX Technologies, Insmed, Kratos Defense & Security Solutions, GE Vernova, and Revolution Medicines.

Why it matters: The filing provides a broad public snapshot that can help diligence readers review issuer breadth, top-position changes, and listed-market themes without treating the 13F as a complete portfolio or performance record.

9AT filing context: Public SEC 13F context for period 2026-03-31 shows 205 listed positions and about $1.4B in information-table value fields; ADV context maps Nicholas to CRD 140159 / SEC file 801-66532 with about $1.5B in reported regulatory AUM.

Summary

Nicholas Investment Partners, L.P. filed a public Form 13F-HR for the quarter ended 2026-03-31. The SEC information table lists 205 positions and about $1.4 billion in aggregate reported value fields. Top reported entries by value included BWX Technologies, Insmed, Kratos Defense & Security Solutions, GE Vernova, and Revolution Medicines.

This is a broad public 13F snapshot. It is useful for tracking listed positions, but it is not a complete portfolio, total AUM, performance record, or recommendation.

Why it matters

For due-diligence readers, a larger 13F can help frame questions about breadth, sector mix, top-position concentration, and turnover. The filing can be compared with future quarters to identify public changes that merit follow-up with manager materials or adviser records.

Source notes

9AT filing context

Public SEC 13F context for period 2026-03-31 shows 205 listed positions and about $1.4 billion in information-table value fields. ADV context maps Nicholas Investment Partners, L.P. to CRD 140159 / SEC file 801-66532 with about $1.5 billion in reported regulatory AUM. 13F and ADV figures should be read within their public-filing limits.

What to watch

Watch future filings for changes in the top reported issuers, additions and exits from the public snapshot, and any amendments that alter the reported information table.

Source links